Intensity Therapeutics, Inc.
INTS
$0.282
-$0.009-3.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.40% | -2.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.30% | 5.96% | |||
| Operating Income | 20.30% | -5.96% | |||
| Income Before Tax | 24.20% | -5.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.20% | -5.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.20% | -5.22% | |||
| EBIT | 20.30% | -5.96% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 39.03% | 0.14% | |||
| Normalized Basic EPS | 39.09% | 0.14% | |||
| EPS Diluted | 39.03% | 50.09% | |||
| Normalized Diluted EPS | 39.09% | 0.14% | |||
| Average Basic Shares Outstanding | 24.35% | 5.36% | |||
| Average Diluted Shares Outstanding | 24.35% | 5.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||